These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 7979255)
21. Toxins affecting calcium channels in neurons. Uchitel OD Toxicon; 1997 Aug; 35(8):1161-91. PubMed ID: 9278968 [TBL] [Abstract][Full Text] [Related]
22. Properties of calcium channels isolated with spider toxin, FTX. Cherksey BD; Sugimori M; Llinás RR Ann N Y Acad Sci; 1991; 635():80-9. PubMed ID: 1683761 [No Abstract] [Full Text] [Related]
23. Pharmacology of N-type Ca2+ channels distributed in cardiovascular system (Review). Uneyama H; Takahara A; Wakamori M; Mori Y; Yoshimoto R Int J Mol Med; 1999 May; 3(5):455-66. PubMed ID: 10202175 [TBL] [Abstract][Full Text] [Related]
24. Effects of toxins on Ca2+ currents and peptide release from nerve terminals. Lemos JR; Wang G; Wang X; Stuenkel EL; Nordmann JJ; Treistman SN Ann N Y Acad Sci; 1994 Mar; 710():11-29. PubMed ID: 8154740 [No Abstract] [Full Text] [Related]
25. Snail and spider toxins share a similar tertiary structure and 'cystine motif'. Narasimhan L; Singh J; Humblet C; Guruprasad K; Blundell T Nat Struct Biol; 1994 Dec; 1(12):850-2. PubMed ID: 7773771 [No Abstract] [Full Text] [Related]
26. [Progress of study on the structure and function of omega-conotoxins]. Chen XY; Zhan JB Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 33(1):85-8. PubMed ID: 14966950 [No Abstract] [Full Text] [Related]
28. Calcium channel blockers: current controversies and basic mechanisms of action. Clusin WT; Anderson ME Adv Pharmacol; 1999; 46():253-96. PubMed ID: 10332505 [No Abstract] [Full Text] [Related]
29. Voltage-gated calcium-channels and antiarrhythmic drug action. Grace AA; Camm AJ Cardiovasc Res; 2000 Jan; 45(1):43-51. PubMed ID: 10728311 [No Abstract] [Full Text] [Related]
30. A new way to spell relief: v-e-n-o-m. A toxin from killer sea snails promises a better painkiller. Gibbs WW Sci Am; 1996 Feb; 274(2):28, 30. PubMed ID: 8560212 [No Abstract] [Full Text] [Related]
31. Spider toxins as tools for dissecting elements of excitatory amino acid transmission. Jackson H; Usherwood PN Trends Neurosci; 1988 Jun; 11(6):278-83. PubMed ID: 2465627 [No Abstract] [Full Text] [Related]
32. The snail companies. Neurex Corporation & Cognetix Inc. Wells WA Chem Biol; 1998 Sep; 5(9):R235-6. PubMed ID: 9755372 [No Abstract] [Full Text] [Related]
34. Calcium channel blockers: what they can and what they can't do. Menè P Nephrol Dial Transplant; 1997 Jan; 12(1):25-8. PubMed ID: 9027768 [No Abstract] [Full Text] [Related]
35. Biophysical and pharmacological characterization of a class A calcium channel. Sather WA; Tanabe T; Zhang JF; Tsien RW Ann N Y Acad Sci; 1994 Dec; 747():294-301. PubMed ID: 7847678 [No Abstract] [Full Text] [Related]
36. Conversion of L- to D-amino acids: a posttranslational reaction. Kreil G Science; 1994 Nov; 266(5187):996-7. PubMed ID: 7973683 [No Abstract] [Full Text] [Related]
37. Nomenclature of calcium channels and channel modulators: IUPHAR classification. Spedding M; Vanhoutte PM J Cardiovasc Pharmacol; 1993 Dec; 22(6):906. PubMed ID: 7509912 [No Abstract] [Full Text] [Related]